http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2159479-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee46356e4404b1463eac34cf69ab734e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56
filingDate 1999-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0511c37e31ddb94eef3b0421765ba43c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e6bc8563f94a49027ef76a0cd55b0e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f99b446a90ea74518a22aeb29ff39161
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbddc2c284e7fa95444bbc8c48e575eb
publicationDate 2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2159479-A1
titleOfInvention NEW INDAZOLS AS INHIBITORS OF CICLOOXIGENASA-II
abstract New indazoles as cyclooxygenase-II inhibitors. The present invention relates to compounds of general formula I, **FORMULA**, selective inhibitors of cyclooxygenase-II, in which group A is a single bond, -O-, -S- or -NH-; R{sup,3} is hydrogen, (C{sub,1}- C{sub,12})-alkyl, (C{sub,2} C{sub,12})-alkenyl, (C{sub,2 }-C{sub,12})-alkynyl, (C{sub,1}-C{sub,12})-haloalkyl, (C{sub,1}-C{sub,12})-alkylcarbonyl, etc, to their pharmaceutically acceptable salts and solvates, and to pharmaceutical compositions containing them. The compounds of the present invention are useful in the treatment of inflammation, pain, and fever, as well as those other conditions that have recently been associated with cyclooxygenases, especially cyclooxygenase-II, such as colorectal cancer and Alzheimer's disease. Similarly, the present invention relates to a process for the preparation of the compounds, as well as their therapeutic use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008053031-A1
priorityDate 1999-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9638442-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0924201-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0922697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5387602-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9822442-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083969-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442942
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407608385

Total number of triples: 26.